Protective B cell responses to Flu-No fluke!

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 3823-3829

  Waffarn, Elizabeth E ^a   Baumgarth, Nicole ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D; DNA VACCINE; IMMUNOGLOBULIN M; INFLAMMASOME; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERFERON; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR;

ADJUVANT THERAPY; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; B LYMPHOCYTE; COMPLEMENT SYSTEM; CROSS REACTION; CYTOKINE PRODUCTION; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS IMMUNITY;

ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; HUMANS; IMMUNIZATION, SECONDARY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LYMPHOID TISSUE; ORTHOMYXOVIRIDAE;

EID: 79954996238     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002090     Document Type: Review

References (76)

1. Kanneganti, T. D. 2010. Central roles of NLRs and inflammasomes in viral infection. Nat. Rev. Immunol. 10: 688-698.
2. + and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159: 105-117. (Pubitemid 27499863)
3. Bruder, D., A. Srikiatkhachorn, and R. I. Enelow. 2006. Cellular immunity and lung injury in respiratory virus infection. Viral Immunol. 19: 147-155. (Pubitemid 44050313)
4. Sealy, R., S. Surman, J. L. Hurwitz, and C. Coleclough. 2003. Antibody response to influenza infection of mice: Different patterns for glycoprotein and nucleocapsid antigens. Immunology 108: 431-439. (Pubitemid 36469680)
5. Clarke, S. H., L. M. Staudt, J. Kavaler, D. Schwartz, W. U. Gerhard, and M. G. Weigert. 1990. V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. J. Immunol. 144: 2795-2801. (Pubitemid 20136692)
6. Kavaler, J., A. J. Caton, L. M. Staudt, and W. Gerhard. 1991. A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. Eur. J. Immunol. 21: 2687-2695.
7. McKean, D., K. Huppi, M. Bell, L. Staudt, W. Gerhard, and M. Weigert. 1984. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 81: 3180-3184. (Pubitemid 14110702)
8. Wrammert, J., K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of highaffinity human monoclonal antibodies against influenza virus. Nature 453: 667-671. (Pubitemid 351769295)
9. Gerhard, W., K. Mozdzanowska, M. Furchner, G. Washko, and K. Maiese. 1997. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159: 95-103. (Pubitemid 27499862)
10. Grebe, K. M., J. W. Yewdell, and J. R. Bennink. 2008. Heterosubtypic immunity to influenza A virus: Where do we stand? Microbes Infect. 10: 1024-1029.
11. Wrammert, J., D. Koutsonanos, G. M. Li, S. Edupuganti, J. Sui, M. Morrissey, M. McCausland, I. Skountzou, M. Hornig, W. I. Lipkin, et al. 2011. Broadly crossreactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208: 181-193.
12. Ekiert, D. C., G. Bhabha, M. A. Elsliger, R. H. Friesen, M. Jongeneelen, M. Throsby, J. Goudsmit, and I. A. Wilson. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324: 246-251.
13. Steel, J., A. C. Lowen, T. T. Wang, M. Yondola, Q. Gao, K. Haye, A. Garcia- Sastre, and P. Palese. 2010. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1: E00018-10.
14. Feng, J., M. Zhang, K. Mozdzanowska, D. Zharikova, H. Hoff, W. Wunner, R. B. Couch, and W. Gerhard. 2006. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol. J. 3: 102.
15. Straight, T. M., M. G. Ottolini, G. A. Prince, and M. C. Eichelberger. 2008. Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats. Virol. J. 5: 44.
16. Carragher, D. M., D. A. Kaminski, A. Moquin, L. Hartson, and T. D. Randall. 2008. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J. Immunol. 181: 4168-4176.
17. Rangel-Moreno, J., D. M. Carragher, R. S. Misra, K. Kusser, L. Hartson, A. Moquin, F. E. Lund, and T. D. Randall. 2008. B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms. J. Immunol. 180: 454-463.
18. Webster, R. G. 1966. Original antigenic sin in ferrets: The response to sequential infections with influenza viruses. J. Immunol. 97: 177-183.
19. Kim, J. H., I. Skountzou, R. Compans, and J. Jacob. 2009. Original antigenic sin responses to influenza viruses. J. Immunol. 183: 3294-3301.
20. Monsalvo, A. C., J. P. Batalle, M. F. Lopez, J. C. Krause, J. Klemenc, J. Z. Hernandez, B. Maskin, J. Bugna, C. Rubinstein, L. Aguilar, et al. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17: 195-199.
21. Couch, R. B., and J. A. Kasel. 1983. Immunity to influenza in man. Annu. Rev. Microbiol. 37: 529-549.
22. Ito, R., Y. A. Ozaki, T. Yoshikawa, H. Hasegawa, Y. Sato, Y. Suzuki, R. Inoue, T. Morishima, N. Kondo, T. Sata, et al. 2003. Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia. Vaccine 21: 2362-2371. (Pubitemid 36561328)
23. Sasaki, S., M. C. Jaimes, T. H. Holmes, C. L. Dekker, K.Mahmood, G.W. Kemble, A. M. Arvin, and H. B. Greenberg. 2007. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J. Virol. 81: 215-228. (Pubitemid 44975162)
24. Holt, P. G., D. H. Strickland, M. E. Wikström, and F. L. Jahnsen. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8: 142-152. (Pubitemid 351161302)
25. Manicassamy, B., S. Manicassamy, A. Belicha-Villanueva, G. Pisanelli, B. Pulendran, and A. García-Sastre. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 107: 11531-11536.
26. Randall, T. D. 2010. Bronchus-associated lymphoid tissue (BALT) structure and function. Adv. Immunol. 107: 187-241.
27. + T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J. Exp. Med. 198: 1011-1021. (Pubitemid 37248617)
28. Gonzalez, S. F., V. Lukacs-Kornek, M. P. Kuligowski, L. A. Pitcher, S. E. Degn, S. J. Turley, and M. C. Carroll. 2010. Complement-dependent transport of antigen into B cell follicles. J. Immunol. 185: 2659-2664.
29. Choi, Y. S., and N. Baumgarth. 2008. Dual role for B-1a cells in immunity to influenza virus infection. J. Exp. Med. 205: 3053-3064.
30. Coro, E. S., W. L. Chang, and N. Baumgarth. 2006. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J. Immunol. 176: 4343-4351. (Pubitemid 44264414)
31. McLaren, C., and G. M. Butchko. 1978. Regional T- and B-cell responses in influenza-infected ferrets. Infect. Immun. 22: 189-194. (Pubitemid 9040717)
32. Tamura, S., and T. Kurata. 2004. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn. J. Infect. Dis. 57: 236-247. (Pubitemid 40260238)
33. Jones, P. D., and G. L. Ada. 1987. Persistence of influenza virus-specific antibodysecreting cells and B-cell memory after primary murine influenza virus infection. Cell. Immunol. 109: 53-64. (Pubitemid 17155708)
34. Rothaeusler, K., and N. Baumgarth. 2010. B-cell fate decisions following influenza virus infection. Eur. J. Immunol. 40: 366-377.
35. McDermott, M. R., and J. Bienenstock. 1979. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122: 1892-1898. (Pubitemid 9175317)
36. Kenyon, N. J., R. Liu, E. M. O'Roark, W. Huang, L. Peng, and K. S. Lam. 2009. An alpha4beta1 integrin antagonist decreases airway inflammation in ovalbuminexposed mice. Eur. J. Pharmacol. 603: 138-146.
37. GeurtsvanKessel, C. H., M. A. Willart, I. M. Bergen, L. S. van Rijt, F. Muskens, D. Elewaut, A. D. Osterhaus, R. Hendriks, G. F. Rimmelzwaan, and B. N. Lambrecht. 2009. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206: 2339-2349.
38. Moyron-Quiroz, J. E., J. Rangel-Moreno, K. Kusser, L. Hartson, F. Sprague, S. Goodrich, D. L. Woodland, F. E. Lund, and T. D. Randall. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10: 927-934. (Pubitemid 39273733)
39. Hyland, L.,M. Sangster, R. Sealy, and C. Coleclough. 1994. Respiratory virus infection of mice provokes a permanent humoral immune response. J. Virol. 68: 6083-6086. (Pubitemid 24258630)
40. Joo, H. M., Y. He, and M. Y. Sangster. 2008. Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia. Proc. Natl. Acad. Sci. USA 105: 3485-3490. (Pubitemid 351723579)
41. Baumgarth, N., O. C. Herman, G. C. Jager, L. Brown, L. A. Herzenberg, and L. A. Herzenberg. 1999. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA 96: 2250-2255. (Pubitemid 29117900)
42. Baumgarth, N., O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192: 271-280. (Pubitemid 30470309)
43. Savitsky, D., and K. Calame. 2006. B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion. J. Exp. Med. 203: 2305-2314. (Pubitemid 44498365)
44. Baumgarth, N. 2011. The double life of a B-1 cell: Self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
45. Hermesh, T., B. Moltedo, T. M. Moran, and C. B. López. 2010. Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe 7: 343-353.
46. Nisitani, S., T. Tsubata, M. Murakami, and T. Honjo. 1995. Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur. J. Immunol. 25: 3047-3052.
47. Ha, S. A., M. Tsuji, K. Suzuki, B. Meek, N. Yasuda, T. Kaisho, and S. Fagarasan. 2006. Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med. 203: 2541-2550. (Pubitemid 44664623)
48. Jayasekera, J. P., E. A. Moseman, and M. C. Carroll. 2007. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J. Virol. 81: 3487-3494. (Pubitemid 46456657)
49. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
50. Bouaziz, J. D., K. Yanaba, and T. F. Tedder. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224: 201-214.
51. Lee, B. O., J. Rangel-Moreno, J. E. Moyron-Quiroz, L. Hartson, M. Makris, F. Sprague, F. E. Lund, and T. D. Randall. 2005. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J. Immunol. 175: 5827-5838. (Pubitemid 41508067)
52. + T-cell activities that enhance the therapeutic activity of antiviral antibodies. J. Virol. 79: 5943-5951. (Pubitemid 40617200)
53. Butchko, G. M., R. B. Armstrong, W. J. Martin, and F. A. Ennis. 1978. Influenza A viruses of the H2N2 subtype are lymphocyte mitogens. Nature 271: 66-67. (Pubitemid 8240066)
54. Scalzo, A. A., and E. M. Anders. 1985. Influenza viruses as lymphocyte mitogens. II. Role of I-E molecules in B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes. J. Immunol. 135: 3524-3529. (Pubitemid 16250627)
55. Marshall-Clarke, S., L. Tasker, O. Buchatska, J. Downes, J. Pennock, S. Wharton, P. Borrow, and D. Z. Wiseman. 2006. Influenza H2 haemagglutinin activates B cells via a MyD88-dependent pathway. Eur. J. Immunol. 36: 95-106. (Pubitemid 43116396)
56. Moyron-Quiroz, J. E., J. Rangel-Moreno, L. Hartson, K. Kusser, M. P. Tighe, K. D. Klonowski, L. Lefrançois, L. S. Cauley, A. G. Harmsen, F. E. Lund, and T. D. Randall. 2006. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 25: 643-654. (Pubitemid 44529043)
57. Paus, D., T. G. Phan, T. D. Chan, S. Gardam, A. Basten, and R. Brink. 2006. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 203: 1081-1091.
58. Jacob, J., and G. Kelsoe. 1992. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J. Exp. Med. 176: 679-687.
59. Roost, H. P., M. F. Bachmann, A. Haag, U. Kalinke, V. Pliska, H. Hengartner, and R. M. Zinkernagel. 1995. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc. Natl. Acad. Sci. USA 92: 1257-1261.
60. Ikonen, N., M. Strengell, L. Kinnunen, P. Osterlund, J. Pirhonen, M. Broman, I. Davidkin, T. Ziegler, and I. Julkunen. 2010. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 15: 19478.
61. Takahashi, Y. 2007. Memory B cells in systemic and mucosal immune response: Implications for successful vaccination. Biosci. Biotechnol. Biochem. 71: 2358-2366. (Pubitemid 350106237)
62. Carroll, M. C. 2004. The complement system in regulation of adaptive immunity. Nat. Immunol. 5: 981-986. (Pubitemid 41057714)
63. Ross, T. M., Y. Xu, R. A. Bright, and H. L. Robinson. 2000. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1: 127-131.
64. Ichinohe, T., H. K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206: 79-87.
65. Schmitz, N., M. Kurrer, M. F. Bachmann, and M. Kopf. 2005. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J. Virol. 79: 6441-6448. (Pubitemid 40617247)
66. Thomas, P. G., P. Dash, J. R. Aldridge Jr., A. H. Ellebedy, C. Reynolds, A. J. Funk, W. J. Martin, M. Lamkanfi, R. J. Webby, K. L. Boyd, et al. 2009. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30: 566-575.
67. Chang, W. L., E. S. Coro, F. C. Rau, Y. Xiao, D. J. Erle, and N. Baumgarth. 2007. Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J. Immunol. 178: 1457-1467. (Pubitemid 46154617)
68. Le Bon, A., C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, U. Kalinke, and D. F. Tough. 2006. Cutting edge: Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176: 2074-2078. (Pubitemid 43201653)
69. Jego, G., A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234. (Pubitemid 37011337)
70. Le Bon, A., G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardelli, and D. F. Tough. 2001. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14: 461-470. (Pubitemid 32441598)
71. Shiow, L. R., D. B. Rosen, N. Brdicková, Y. Xu, J. An, L. L. Lanier, J. G. Cyster, and M. Matloubian. 2006. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544.
72. Rau, F. C., J. Dieter, Z. Luo, S. O. Priest, and N. Baumgarth. 2009. B7-1/2 (CD80/CD86) direct signaling to B cells enhances IgG secretion. J. Immunol. 183: 7661-7671.
73. Avalos, A. M., L. Busconi, and A. Marshak-Rothstein. 2010. Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity 43: 76-83.
74. Bekeredjian-Ding, I., and G. Jego. 2009. Toll-like receptors-sentries in the B-cell response. Immunology 128: 311-323.
75. Heer, A. K., A. Shamshiev, A. Donda, S. Uematsu, S. Akira, M. Kopf, and B. J. Marsland. 2007. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178: 2182-2191. (Pubitemid 46233416)
76. Geeraedts, F., N. Goutagny, V. Hornung, M. Severa, A. de Haan, J. Pool, J. Wilschut, K. A. Fitzgerald, and A. Huckriede. 2008. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog. 4: E1000138.